United States · 
Who invested in ImmuneSensor Therapeutics?
ImmuneSensor Therapeutics's investors include Revent.
United States · Series A startup
Who invested in ImmuneSensor Therapeutics
Funding summaryUpdated 26 Oct 2026
$10Mraised across 1 round since 2022, from 1 source
- Latest round
- Series A, $10MDec 2022
- Investors
- 1
The rounds
- Dec 2022
Founders and team
From ImmuneSensor Therapeutics's own website and the SEC filings it signed: 1 founder, 4 on the team.
Jet LiBoard Chairman and Co-Founder
- Betty LawrenceVP, Toxicology and Regulatory
- Teresa MooneyhamVP, Clinical Operations & Head of Project Management
- Ernest WongExecutive Officer, Directori
- Qingsong LiExecutive Officer, Directori
On the board, as filediNing ZhangZhi Hong
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about ImmuneSensor Therapeutics
How much has ImmuneSensor Therapeutics raised?
ImmuneSensor Therapeutics has raised $10M across 1 round since 2022.
When did ImmuneSensor Therapeutics last raise?
ImmuneSensor Therapeutics's most recent round was a Series A of $10M in Dec 2022.
What was ImmuneSensor Therapeutics's biggest round?
Its most recent round, $10M in Dec 2022, is also its largest on record.
Who backed ImmuneSensor Therapeutics first?
ImmuneSensor Therapeutics's first round on record, in Dec 2022, was backed by Revent.
What stage is ImmuneSensor Therapeutics at?
ImmuneSensor Therapeutics's latest named round is a Series A, in Dec 2022.
Where is ImmuneSensor Therapeutics based?
ImmuneSensor Therapeutics is based in the United States.
Companies like ImmuneSensor Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.